CeriBell Inc

NASDAQ:CBLLUnited States

Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.

Contact Information

Headquarters

360 N. PASTORIA AVENUESUNNYVALE, CA, United States 94085

Phone

302-658-7581

Fax

302-655-5049

Executives

Independent Chairman of the Board

Rebecca Robertson

President, Chief Executive Officer, Director, Co-Founder

Xingjuan Chao

Chief Financial Officer

Scott Blumberg

Chief Technology Officer

Raymond Woo

Director, Chief Medical Adviser, Co-Founder

Josef Parvizi